Muge Aygen

PUBLICATIONS - REASEARCH - PRESENTATIONS *

Manuscripts:

  • Aygen M, I.E. Akduman, M. M. Osman. Bladder EAR: A Potential Source of False Interpretation in F-18 FDG PET. Clinical Nuclear Medicine 2008 Oct; 33 (10): 721-2.
  • Aygen M, Amirmokri P, Berk F, Nguyen N, Civelek A.C, Bastani B. A Preliminary Report on 99mTc-Fanolesomab Imaging of Renal Allograft. Nuclear Medicine Communications-in print. IRB#: 14094
  • Mudun A, Aslay I, Aygen M, Muslumanoglu M, Bozfakioğlu Y, Cantez S. Can preoperative lymphoscintigraphy be used as a guide in treatment planning of breast cancer?. Clinical Nuclear Medicine, May, 2001. 26; 405-11
  • Kurul S, Mudun A, Aksakal N, Aygen M. Lymphatic Mapping for Merkel Cell Carcinoma. Plastic and Reconstructive Surgery, 2000. 105:2; 680-3
  • Aygen M, Mudun A, Kurul S, Camlıca H, Buyukbabani S, Cantez S, "Developed Methods of Evaluation of Sentinel Lymph Node in Malign Melanoma", Turkish Journal of Oncology,2000. 15; 51-6

Abstracts:

  • M.Aygen, F. Berk, B.Bastani, F.Qazi, A.C. Civelek. Detection of infection in arteriovenous fistula (AVF) versus arterio venous graft (AVG) and hemodialysis (HD) catheter by invivo labeled Tc-99m WBC imaging. European Journal of Nuclear Medicine and Molecular Imaging (EANM) 2007. 34: s2, 609P.
  • F.Berk, M.Aygen, B.Bastani, F.Qazi, A.C.Civelek. The effect of recent hemodialysis on invivo labeled 99mTc WBClung retention in patients with end stage renal disease (ESRD). European Journal of Nuclear Medicine and Molecular Imaging (EANM) 2007. 34: s2, 606P.
  • M. Aygen, E. C. Hsueh, N. Nguyen, M Romero, D. Prohazka ,C.A. Civelek.2-Deoxy-2-[18F]Fluoro-D-Glucose-PET/CT is more accurate and sensitive detecting axillary metastases in patients with lymphovascular invasion and/or large breast tumor. Molecular Imaging and Biology 2006. 8:2;116.
  • M. Aygen, B. Bastani, F. Berk, P. Amirmokri, N. Nguyen, C.A.Civelek. Use of Tc-99m-fanolesomab scans for evaluation of vascular access site infection in dialysis patients. Journal of Nuclear Medicine, 2006. 47;151P-a.
  • N.C. Nguyen, R.E. Hogan, M. Aygen, C. A. Civelek, M. M. Osman. Increased F-18 FDG Uptake in the Posterior Ocular Bulb may Indicate Brain Metastases: An initial Study. Journal of Nuclear Medicine, 2006. 47; 303P
  • M. Aygen, P. Amirmokri, F. Berk1, N. Nguyen, C.A. Civelek and B. Bastani. A preliminary report on NeutroSpec imaging of renal allograft. Journal of Nuclear Medicine, 2006. 47; 360P-a.
  • M. Aygen, F. Berk, E. C. Hsueh, I. Akduman, N. Nguyen, M. Romero, D. Prohazka and C.A. Civelek F-18 FDG-PET/CT to detect axillary node metastases in patients with large breast tumors and lymphovascular invasion. Journal of Nuclear Med, 2006. 47; 441P.
  • M. Aygen, F. Berk, N. Nyguen, G. Ege, Z. Cseri, E. C. Hsueh, C.A. Civelek. Basic Training in sentinel node lymphoscintigraphy is sufficient to produce successful results. Journal of Nuclear Medicine, 2006. 47; 456P-a.
  • F. Berk, M. Aygen, B. Bastani, C.A.Civelek. Tc-99m Fanolesomab lung retention in patients with end stage renal disease (ESRD) with/without clinical coronary artery disease (CAD).World Journal of Nuclear Medicine 2006. 5:1; s54.
  • F. Berk, M. Aygen, J.A. Siegel, A. C. Civelek. The low incidence of increased thyroid burden in personnel who administer therapeutic doses of I-131. World Journal of Nuclear Medicine. 2006.5:1; s48.
  • Aygen M, Mudun A, Bozfakıoglu Y, Cantez S. Concomitant Lymphoscintigraphy, Blue Dye and Surgical Gamma Probe use to evaluate Axillary Sentinel Lymph Node in Breast Cancer. Turkish Journal of Nuclear Medicine. 2000. 9:1, s100,
  • Mudun A, Aygen M, Aslay I, Bozfakioglu Y, Muslumanoglu, M, Dincag A, Cantez S. Preoperative lymphatic mapping and sentinel node localization as a useful guide in patients with breast cancer, European Journal of Nuclear Medicine. 1999. 26, s84.
  • Aygen M, Kurul S, Mudun A, Aydıner A, Cantez S. The success andeffectiveness of concomitant metilen-blue dye and lymphoscintigraphyuse to detect sentinel lymph node in Malign Melanoma without using intraoperative gamma-probe , Turkish Journal of Nuclear Medicine. 1999. 8:1, s17.
  • Mudun A , Aslay I, Aygen M, Muslumanoglu M, Bozfakioglu Y, Cantez. Can Preoperative lymphatic mapping be used as a guide in the treatment of breast cancer ? European Journal of Nuclear Medicine 1998. 25, s1039.

QUALIFICATIONS

  • Diagnostic radiology board eligible, (ABR) expected to complete in June 2011.
  • American Board of Nuclear Medicine (ABNM) Eligible.
  • United States Medical Licensing examination, 2003.

Education

Education

ANKARA MEDICAL SCHOOL

ISTANBUL UNIVERSITY HOSPITAL

Resident, Nuclear Medicine

Studied and participate in:

  • Cardiac Imaging
  • Extensive endocrine imaging including high dose thyroid cancer treatment
  • Gained Nuclear Medicine Board by Turkish Board of Nuclear Medicine
Jul 2007 - Present

ST. LOUIS UNIVERSITY HOSPITAL

Resident, Diagnostic Radiology

Have studied and participated in:

  • Pediatric Radiology - 6 months
  • Breast Imaging with mammography, ultrasound, stereotactic biopsy and MRI - 4 months
  • General and obstetrical ultrasound - 6 months
  • Chest Imaging - 5 months
  • Gastrointestinal imaging - 5 months
  • Abdominal Imaging with advanced training in body MRI - 4 months
  • Musculoskeletal Imaging with advanced training in musculoskeletal MRI- 4 months
  • Interventional Radiology - 7 months
  • Cardiac MRI - 1 month
  • Breast Imaging at Brigham and Women's Hospital in Boston (external rotation) - 1 month
Jul 2006 - Jul 2007

ST. LOUIS UNIVERSITY HOSPITAL

Resident, Nuclear Medicine

Studied and participated in:

  • Cardiac Imaging
  • Tumor Imaging with advanced training in PET/CT - 6 months
Mar 2005 - Jul 2006

ST. LOUIS UNIVERSITY HOSPITAL

Visiting Scientist, Nuclear Medicine

Studied and participated in:

  • Multiple research projects including multiple abstracts and manuscript.
  • Interdisciplinary Tumor Conferences